Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sagimet Biosciences Inc. Series A Common Stock

SGMT
Current price
5.18 USD -0.72 USD (-12.20%)
Last closed 6.02 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 191 240 080 USD
Yield for 12 month +109.72 %
1Y
3Y
5Y
10Y
15Y
SGMT
21.11.2021 - 28.11.2021

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, a once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. Address: 155 Bovet Road, San Mateo, CA, United States, 94402

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

32.6 USD

P/E ratio

Dividend Yield

Current Year

+2 000 000 USD

Last Year

Current Quarter

Last Quarter

Current Year

+2 000 000 USD

Last Year

-130 000 USD

Current Quarter

Last Quarter

Key Figures SGMT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM -1813.75 %
PE Ratio
Return On Assets TTM -21.54 %
PEG Ratio
Return On Equity TTM -29.32 %
Wall Street Target Price 32.6 USD
Revenue TTM 2 000 000 USD
Book Value 5.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.92 USD
Diluted Eps TTM -0.92 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SGMT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SGMT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SGMT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 12.5102
Price Sales TTM 95.62
Enterprise Value EBITDA -1.9295
Price Book MRQ 1.0434

Financials SGMT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SGMT

For 52 weeks

2.25 USD 20.71 USD
50 Day MA 4.25 USD
Shares Short Prior Month 1 971 420
200 Day MA 4.64 USD
Short Ratio 1.32
Shares Short 3 982 642
Short Percent 14.78 %